Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAME METFO: Fenofibrate + Metformin vs Metformin in T2DM
NCT00362323Phase 3Completed
- Sponsor
- Solvay
- Start
- Oct 2006
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 3, randomised, double-blind trial of fenofibrate in dyslipidemia (2 arms), sponsored by Solvay. Primary endpoint: Triglyceride / High-Density Lipoprotein Cholesterol Ratio at 24 weeks. Started Oct 2006; status: completed.
02
Drugs
fenofibrate
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00362323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00362323.